NovaBay Pharma (NBY) Posts Wider than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Total operating expenses: 4.89M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Total operating expenses: 4.89M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
NovaBay Pharmaceuticals, Inc. (AMEX: NBY) reported Q1 loss of ($0.08), $0.03 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $2.22 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
